ストックスクリーナーアプリを入手
10.15
5.84%
0.56
アフターアワーズ：
10.19
0.04
+0.39%
前日終値:
$9.59
開ける：
$9.58
24時間の取引高:
1.50M
Relative Volume:
1.35
時価総額：
$615.87M
収益：
$65,400
当期純損益:
$-46.34M
株価収益率:
-11.80
EPS:
-0.86
ネットキャッシュフロー:
$-38.74M
1週間 パフォーマンス:
-21.74%
1か月 パフォーマンス:
+14.04%
6か月 パフォーマンス:
+73.80%
1年 パフォーマンス:
+190.83%
1日の値動き範囲:
$9.58
$10.28
1週間の範囲:
$9.40
$11.94
52週間の値動き範囲:
$2.57
$13.85
CorMedix Inc Stock (CRMD) Company Profile
名前
CorMedix Inc
セクター
電話
908-517-9500
住所
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-02-17 | 開始されました | Needham | Buy |
| 2020-09-29 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-09-21 | 開始されました | Truist | Buy |
| 2019-12-18 | 開始されました | B. Riley FBR | Buy |
| 2019-03-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-12-06 | 開始されました | ROTH Capital | Buy |
| 2017-09-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-08-10 | 繰り返されました | Rodman & Renshaw | Buy |
| 2017-05-05 | 繰り返されました | Rodman & Renshaw | Buy |
| 2016-11-11 | 繰り返されました | FBR & Co. | Outperform |
| 2016-03-17 | 繰り返されました | FBR Capital | Outperform |
| 2016-03-03 | 開始されました | FBR Capital | Outperform |
| 2015-11-16 | 繰り返されました | ROTH Capital | Neutral |
| 2015-10-29 | 繰り返されました | ROTH Capital | Neutral |
| 2015-05-06 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 繰り返されました | ROTH Capital | Buy |
| 2011-10-03 | ダウングレード | Maxim Group | Buy → Hold |
すべてを表示
CorMedix Inc (CRMD) 最新ニュース
CorMedix's SWOT analysis: defencath launch boosts stock outlook - Investing.com India
CorMedix's SWOT analysis: defencath launch boosts stock outlook By Investing.com - Investing.com UK
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium - The Manila Times
Analysts Just Made A Massive Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts - Simply Wall St
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic - Yahoo Finance UK
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate - Yahoo Finance UK
Recent 23% pullback isn't enough to hurt long-term CorMedix (NASDAQ:CRMD) shareholders, they're still up 188% over 1 year - Simply Wall St
CorMedix Inc. (NASDAQ:CRMD) Q3 2024 Earnings Call Transcript - Insider Monkey
CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates - MSN
CorMedix Inc. Reports Q3 2024 Financial Results - TipRanks
CorMedix (CRMD) Q3 2024 Earnings Call Transcript - The Motley Fool
Earnings call: CorMedix Inc. reports Q3 financials, DefenCath drives growth - Investing.com
Earnings call: CorMedix Inc. reports Q3 financials, DefenCath drives growth By Investing.com - Investing.com UK
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
CorMedix: Q3 Earnings Snapshot - Press of Atlantic City
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update - The Manila Times
CorMedix earnings beat by $0.06, revenue topped estimates - Investing.com UK
CorMedix Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Stellantis N.V. (STLA-N) QuotePress Release - The Globe and Mail
Cormedix Inc (CRMD) Q3 2024 Earnings Report Preview: What To Loo - GuruFocus.com
CorMedix stock soars to 52-week high, hits $13.52 - Investing.com India
CorMedix 2.0: New Leadership, New Approval, New Focus (NASDAQ:CRMD) - Seeking Alpha
CorMedix stock soars to 52-week high, hits $13.52 By Investing.com - Investing.com UK
(CRMD) Trading Advice - Stock Traders Daily
Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital + - Seeking Alpha
Spotify Technology S.A. (SPOT-N) QuotePress Release - The Globe and Mail
CorMedix Inc. Announces New Data at ASN Kidney Week 2024 - The Manila Times
Mauritian Rupee/U.S. Dollar (MURUSD) QuotePress Release - The Globe and Mail
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024 - The Manila Times
CorMedix Inc. (CRMD): A Bull Case Theory - Insider Monkey
Teucrium Wheat (WEAT-A) QuotePress Release - The Globe and Mail
CorMedix stock soars to 52-week high, hits $11.07 By Investing.com - Investing.com Australia
CorMedix stock soars to 52-week high, hits $11.07 - Investing.com
CorMedix Stock: Delayed Approval, Low Cash, Good Prospects (NASDAQ:CRMD) - Seeking Alpha
Objective long/short (CRMD) Report - Stock Traders Daily
Views of Wall Street’s Leading Experts on CorMedix Inc - SETE News
CRMD underperforms with a -0.59 decrease in share price - US Post News
CorMedix stock soars to 52-week high, hits $10.15 By Investing.com - Investing.com Australia
CorMedix stock soars to 52-week high, hits $10.15 - Investing.com India
Cormedix stock positioned for growth as DefenCath launch gains traction in 2H24 By Investing.com - Investing.com South Africa
CorMedix Inc (CRMD) receives a Buy rating from Rodman & Renshaw - Knox Daily
Stocks of CorMedix Inc (CRMD) are poised to climb above their peers - SETE News
CorMedix Inc Inc. (CRMD) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Cormedix stock positioned for growth as DefenCath launch gains traction in 2H24 - Investing.com Australia
Deeper Dive: Understanding CorMedix Inc (CRMD) Through its Various Ratios - The Dwinnex
CorMedix Stock Trends After New Commercial Agreement with Dialysis Operator: Retail Spirit Stays ‘Bullish’ - Barchart
CorMedix Inc (CRMD) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
CorMedix Inc (CRMD) 財務データ
収益
当期純利益
現金流量
EPS
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):